ABT-335 and rosuvastatin calcium
Sponsors
Abbott, AstraZeneca
Conditions
Coronary Heart DiseaseDyslipidemiaHypercholesterolemiaMixed Dyslipidemia
Phase 3
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
CompletedNCT00300430
Start: 2006-09-30Updated: 2009-07-23
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
CompletedNCT00463606
Start: 2007-04-30End: 2008-02-29Updated: 2012-10-03